Boughton Soleil's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Feb 16, 2023
- Accession no.
- 0001773751-23-000008
- Filed
- Feb 16, 2023
- Trade date
- Feb 14-15, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $669.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Boughton SoleilCIK 0001837817 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2023 | Class A Common Stock | SSaleDisposed | −2,000 | $9.46 | −$18,920 | 235,089 | Direct | |
| Feb 15, 2023 | Class A Common Stock | SSaleDisposed | −65,000 | $10.01F2 | −$650,650 | 170,089 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $10.00 - $10.03. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.